Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:hedge_fund
|
| gptkbp:bench |
gptkb:Russell_3000_Health_Care_Index
|
| gptkbp:category |
Health
|
| gptkbp:CUSIP |
872005604
|
| gptkbp:distributor |
gptkb:T._Rowe_Price_Associates,_Inc.
|
| gptkbp:dividendPaying |
annual
|
| gptkbp:expenseRatio |
0.77% (as of 2023)
|
| gptkbp:family |
gptkb:T._Rowe_Price
|
| gptkbp:fullName |
gptkb:T._Rowe_Price_Health_Sciences_Fund
|
| gptkbp:fundedBy |
open-end mutual fund
|
| https://www.w3.org/2000/01/rdf-schema#label |
THCNX
|
| gptkbp:investedIn |
healthcare sector
Invests primarily in companies in the health sciences sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. |
| gptkbp:load |
no-load
|
| gptkbp:manager |
gptkb:Ziad_Bakri
|
| gptkbp:minimumInvestment |
$2,500
|
| gptkbp:netWorth |
over $10 billion (as of 2023)
|
| gptkbp:startYear |
December 29, 1995
|
| gptkbp:stockSymbol |
gptkb:THCNX
|
| gptkbp:bfsParent |
gptkb:Chiang_Mai_Province
|
| gptkbp:bfsLayer |
5
|